Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy.
Chen
Eric
E
Retina Service, Wills Eye Hospital, Philadelphia, Pennsylvania 19107, USA.
Park
Carl H
CH
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003131:Combined Modality Therapy; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003930:Diabetic Retinopathy / Q000150:complications*; D019773:Epiretinal Membrane / Q000601:surgery; D006801:Humans; D007267:Injections; D017075:Laser Coagulation; D008297:Male; D012163:Retinal Detachment / Q000188:drug therapy* / Q000601:surgery*; D013459:Sulfur Hexafluoride / Q000008:administration & dosage; D014821:Vitrectomy; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D013459:Sulfur Hexafluoride